ChAracterization of Patients and Treatment OUtcomes in Severe Tricuspid Regurgitation
Recruiting · NCT06838611 · Observational (researchers observe without assigning treatment) · Lead sponsor: Medical University of Warsaw
View the official record on ClinicalTrials.gov →Interventions studied
Transcatheter edge-to-edge repair
What this trial is about
The goal of this observational study is to characterize the population of patients qualified for transcatheter tricuspid valve interventions (TTVI). It is expected to: * Describe the profile of patients qualified for TTVI * Establish the most common causes for disqualification from TTVI * Evaluate the immediate and long-term efficacy of TTVI * Evaluate TTVI safety Participants will undergo a standard qualification procedure for TTVI and then will be subject to a follow-up consisting of clinical examination, echocardiography and laboratory testing.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- tricuspid regurgitation
- qualification for transcatheter tricuspid valve intervention
Exclusion criteria
- tricuspid regurgitation qualified for surgical treatment
- concomitant left heart valve disease qualified for surgical treatment
- multivessel coronary artery disease qualified for coronary artery bypass grafting
- lack of patient's consent to enter the registry
Where it is running
1 location listed.
- First Department of Cardiology, Medical University of Warsaw - Warsaw, Masovian Voivodeship, Poland